Athanor Capital, LP Heron Therapeutics, Inc. Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$14.49 - $20.72 $273,643 - $391,297	-18,885 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $619,975 - $939,510	-42,435 Reduced 69.2%	18,885 $400,000
Q3 2020 Nov 16, 2020	BUY	$13.67 - $17.77 $506,856 - $658,876	37,078 Added 152.95%	61,320 $909,000
Q2 2020 Aug 13, 2020	BUY	$10.89 - $21.47 $263,995 - $520,475	24,242 New	24,242 $357,000
Q2 2018 Aug 13, 2018	SELL	$26.4 - $42.0 $924,000 - $1.47 Million	-35,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$18.43 - $28.8 $645,050 - $1.01 Million	35,000 New	35,000 $966,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.